dendreon corp (DNDN:NASDAQ GS)
Earnings & Estimates Summary - DENDREON CORP (DNDN)
2013 revenues at Dendreon Corp. totaled $283.7M USD, while annual losses equaled $1.11 per share.
Quarterly Earnings & Estimates - DENDREON CORP (DNDN)
Dendreon Corp.'s Quarterly Earnings
Dendreon Corp. reported 2nd quarter 2014 on 08/14/2014.
Annual Earnings & Estimates - DENDREON CORP (DNDN)
Dendreon Corp.'s Annual Earnings
Dendreon Corp. reported annual 2013 losses of $1.11 per share on 03/5/2014.
Quarterly Revenues - DENDREON CORP (DNDN)
Dendreon Corp.'s Quarterly Revenues
Dendreon Corp. had 2nd quarter 2014 revenues of $82.2M USD. This bettered the $72.9M USD consensus of the 10 analysts covering the company. This was 12.1% above the prior year's 2nd quarter results.
Annual Revenues - DENDREON CORP (DNDN)
Dendreon Corp.'s Annual Revenues
Dendreon Corp. had revenues for the full year 2013 of $283.7M USD. This was -12.8% below the prior year's results.
|CTI BioPharma Corp||$2.56 USD||+0.01|
|Pfizer Ltd/India||1,423 INR||-14.95|
|Rigel Pharmaceuticals Inc||$2.60 USD||+0.04|
|Spectrum Pharmaceuticals Inc||$8.11 USD||+0.14|
|Wyeth Ltd||985.00 INR||0.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|